Imanova is pleased to announce further expansion of its preclinical team, with the addition of new roles in both Chemistry and Biology. These new roles bring additional capacity and a broadening of capabilities to Imanova’s leading preclinical imaging offering.
Imanova appoints Preclinical Business Development Manager
Imanova continues to grow its preclinical offering, to respond to an increased demand from the pharmaceutical market, and is pleased to announce the appointment of a new Preclinical Business Development Manager, Julian Westerman.
Imanova choses the Down’s Syndrome Association as Charity of the Year
Imanova as selected the national charity, the Down’s Syndrome Association (DSA) as their Charity of the Year 2017.
Kevin Cox, Imanova’s Chief Executive Officer commented, “Imanova is delighted to support the Down’s Syndrome Association as our Charity of the Year. We are committed to helping the community, therefore, each year we organise and participate in several events; like charity runs, bake-offs, International Food Day to raise money to support an institution.
Molecular Imaging Analysis for Tracer Validation and Clinical Trials – video presentation
Roger Gunn, CSO at Invicro UK (formerly Imanova), was this year’s invited lecturer at the Human Amyloid Imaging Conference.